Back to search

National and Kapodistrian University of Athens

Clinical phenotype of systemic lupus erythematosus (SLE) at first diagnosis in hospitalized patients

Abstract

dc:description

Background: Systemic lupus erythematosus (SLE) is the prototype multisystem autoimmune disorder characterized by a broad spectrum of organ involvement and laboratory abnormalities, spanning a spectrum from mild to life-threatening disease. Occasionally, SLE can first present during hospitalization; prompt recognition in such patients who present with severe disease is essential to initiate treatment. Nevertheless, clinical heterogeneity and lack of pathognomonic clinical and serological features pose a considerable challenge in the diagnosis of SLE, which remains largely clinical, is typically however accompanied by characteristic immunologic features. Classification criteria are often used to support the diagnosis, yet with significant caveats, underlying the need for new diagnostic tools. Of note, the median reported delay from symptom onset to SLE diagnosis is approximately 2 years, a substantially long period during which significant organ damage might accumulate, resulting in adverse outcomes for overall prognosis. Accordingly, early diagnosis of SLE is crucial, to allow early intervention and improve short- and long-term outcomes. Objectives: Herein, we sought to characterize the phenotype of hospitalized patients with new-onset SLE and assess the diagnostic performance of the SLE Risk Probability Index (SLERPI) in this setting, and further explore the patient journey from first symptoms to definite diagnosis, estimate diagnostic delays and associated factors; last, we assessed whether delay in diagnosis is associated with more damage accrual at the time of diagnosis. Methods: Single-centre observational study of SLE patients from the ‘Attikon’ lupus cohort. To define clinical presentation in patients first diagnosed during hospitalization, disease manifestations were categorized in 10 domains based on system organ involvement that led to hospitalization. Disease features, time to diagnosis, classification criteria and the SLERPI were recorded for each patient. Regarding patients’ journey until diagnosis, we included SLE patients with disease duration <6 years. Data were collected from patient charts, structured interviews, and in-person clinical visits. Total delay was divided in i) time from symptom onset to first physician visit, ii) time from first visit to assessment by rheumatologist, and iii) time from first rheumatology assessment to final diagnosis. Initial symptoms, respective lag times, number and specialty of visited physicians, possible alternative diagnoses, and the Systemic Lupus International Collaborating Clinics (SLICC) Damage Index (SDI) at the time of diagnosis were recorded for each patient. Early diagnosis was defined as a diagnosis within 6 months from symptom onset. Results: 191 patients (22.3% of the total cohort) were hospitalized due to manifestations eventually attributed to SLE. Main causes of admission were neuropsychiatric syndromes (21.4%), cytopenias (17.8%), nephritis (17.2%) and thrombotic events (16.2%). Although 79.5% of patients were diagnosed within 3 months from hospitalization, in 39 patients, diagnosis was delayed, particularly in those with hematological manifestations. At hospitalization, a SLERPI >7 (indicating high probability for SLE) was found in 87.4% of patients. Patients missed by the SLERPI (n=24) had fever, thrombotic or neuropsychiatric manifestations not included in the algorithm. Notably, 9 patients from the latter subgroup met the EULAR/ACR criteria. Lowering the SLERPI threshold to 5 in patients with fever or thrombotic events increased the diagnostic rate from 88.8% to 97.9% in this subgroup, while inclusion of all neuropsychiatric events yielded no additional diagnostic value. Regarding diagnostic delay, we mapped the patient journey until diagnosis in 275 patients. Most common initial symptoms were arthritis/arthralgia (74.5%) and rashes (61.8%). Median (IQR) total delay between symptom onset and SLE diagnosis was 24 (54) months. An “early” diagnosis was achieved only in 28.4% of patients, 55.6% were diagnosed after > 12 months, and patients consulted an average of 3 different physicians before reaching diagnosis. Oral ulcers (OR 3.55; 95% CI 1.45-8.70) and malar rash (OR 1.99; 95% CI 1.00-3.94) as initial symptoms, and first medical assessment by orthopedic (OR 5.18; 95% CI 1.47-18.20) were independently associated with a delayed diagnosis. The latter was also associated with increased SDI at the time of diagnosis (OR 2.42; 95% CI 1.03-5.69), attributed mainly to neuropsychiatric and thrombotic events. Conclusions: One in five patients with new-onset SLE present with disease presentations that necessitate hospitalization. Although an early diagnosis was achieved in the majority of cases with in-hospital diagnosis, the latter was still delayed in approximately 20% of patients. A lower SLERPI cut-off (≥5) in patients with fever or thrombosis could enhance early diagnosis. In our whole cohort, diagnosis of SLE was delayed by more than 6 months in three quarters of patients and was associated with more damage accrual, underlying the need for earlier SLE diagnosis and treatment initiation.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kapsala, Noemin
  • Καψάλα, Νωεμίν

Subjects

dc:subject × 16

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61335

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kapsala, Noemin; Καψάλα, Νωεμίν. Clinical phenotype of systemic lupus erythematosus (SLE) at first diagnosis in hospitalized patients. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/61335